BOC-L-PYROGLUTAMIC ACID BENZYL ESTER Chemical Properties

Melting point:

69-70 °C

Boiling point:

464.9±38.0 °C(Predicted)

Density 

1.219

storage temp. 

2-8°C

pka

-4.32±0.40(Predicted)

form 

Powder

color 

White

InChI

InChI=1S/C17H21NO5/c1-17(2,3)23-16(21)18-13(9-10-14(18)19)15(20)22-11-12-7-5-4-6-8-12/h4-8,13H,9-11H2,1-3H3/t13-/m0/s1

InChIKey

TZNBTMCEMLXYEM-ZDUSSCGKSA-N

SMILES

N1(C(OC(C)(C)C)=O)C(=O)CC[C@H]1C(OCC1=CC=CC=C1)=O

CAS DataBase Reference

113400-36-5

Safety Information

HS Code 

2933998090

BOC-L-PYROGLUTAMIC ACID BENZYL ESTER Usage And Synthesis

Uses

Boc-L-pyroglutamic acid benzyl ester is an intermediate in the synthesis of Avibactam, a novel non-beta-lactam β-lactamase inhibitor used in combination with ceftazidime for the treatment of complicated intra-abdominal infections, urinary tract infections, and pneumonia.

Synthesis

General procedure for the synthesis of benzyl (S)-2-(tert-butyl) 5-oxopyrrolidine-1,2-dicarboxylate from di-tert-butyl dicarbonate and benzyl (S)-5-oxopyrrolidine-2-carboxylate: Benzyl (S)-5-oxopyrrolidine-2-carboxylate (8 g, 36.5 mmol, 1 equiv.) was dissolved in dichloromethane (150 mL). The mixture was stirred and cooled to 0°C. 4-Dimethylaminopyridine (DMAP, 4.9 g, 40.1 mmol, 1.1 eq.) and di-tert-butyl dicarbonate ((Boc)2O, 8.75 g, 40.1 mmol, 1.1 eq.) were added sequentially. The reaction mixture was slowly warmed to room temperature and stirring was continued for 2 hours. Upon completion of the reaction, the reaction mixture was diluted with dichloromethane (250 mL) and washed sequentially with 1N aqueous hydrochloric acid (50 mL), saturated aqueous sodium bicarbonate (350 mL) and saturated aqueous sodium chloride. The organic phase was dried over anhydrous sodium sulfate, concentrated under reduced pressure, and purified by silica gel column chromatography to afford the target product (S)-benzyl 2-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate (8.6 g, 73.8% yield). lc-MS (ESI+, m/z = 656, [2M + NH4]+).

References

[1] Tetrahedron Letters, 2002, vol. 43, # 19, p. 3499 - 3501
[2] Chemistry (Weinheim an der Bergstrasse, Germany), 2002, vol. 8, # 11, p. 2516 - 2525
[3] Journal of the Chemical Society - Perkin Transactions 1, 1996, # 6, p. 507 - 514
[4] Tetrahedron, 2004, vol. 60, # 45, p. 10277 - 10284
[5] Patent: US2014/248242, 2014, A1. Location in patent: Paragraph 0402; 0404

BOC-L-PYROGLUTAMIC ACID BENZYL ESTER(113400-36-5)Related Product Information

• (2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid
• N-BOC-CIS-4-CYANO-L-PROLINE METHYL ESTER
• Velpatasvir intermediate
• Velpatasvir
• Velpatasvir intermediate
• Velpatasvir intermediate
• (R)-2-(methoxycarbonylamino)-2-phenylacetic acid
• Velpatasvir Co Povidone
• Velpatasvir intermediate
• (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid
• Velpatasvir-A12